Nursing Strategies for Preventing Ventilator-Associated Pneumonia in Intensive Care Units

Introduction

Ventilator-associated pneumonia, defined as pneumonia developing more than 48 hours after endotracheal intubation and initiation of mechanical ventilation, remains among the most common and costly healthcare-associated infections acquired in the intensive care unit, associated with prolonged mechanical ventilation, extended intensive care unit and hospital stay, and substantial attributable cost, though its independent contribution to mortality has been debated across the epidemiological literature (Rello et al., 2002; Zilberberg & Shorr, 2010).

A range of prevention strategies directly implementable by bedside nursing staff has been developed and evaluated over the past several decades, including structured oral care and antiseptic protocols targeting oropharyngeal bacterial colonization, semi-recumbent positioning to reduce aspiration risk, and subglottic secretion drainage using specialized endotracheal tubes to remove secretions pooling above the endotracheal cuff before they can be aspirated (Klompas et al., 2014). National clinical practice guidelines and quality improvement frameworks, including the Institute for Healthcare Improvement’s ventilator bundle, have incorporated combinations of these strategies into standardized, multicomponent prevention protocols, reflecting an assumption that combined implementation produces benefit beyond any single component alone (Resar et al., 2005).

While prior systematic reviews have evaluated several of these prevention strategies individually, including subglottic secretion drainage and oral hygiene interventions specifically, comparatively fewer syntheses have directly compared effect magnitude across all major nursing-implementable intervention categories within a single updated review, limiting the ability to identify which specific strategy, or combination of strategies, offers the greatest benefit relative to its resource and training requirements (Muscedere et al., 2011; Shi et al., 2013; Labeau et al., 2011). The purpose of this systematic review and meta-analysis was to synthesize randomized controlled trial evidence evaluating nursing-implementable strategies for preventing ventilator-associated pneumonia among mechanically ventilated intensive care unit patients, with a pre-specified comparison across four intervention categories: oral care and antiseptic protocols, semi-recumbent positioning, subglottic secretion drainage, and combined multicomponent bundles.

Methods

Protocol and reporting. This systematic review was conducted and reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 statement (Page et al., 2021). The review protocol was registered prior to data extraction.

Search strategy. A systematic search of MEDLINE, CINAHL, Embase, and the Cochrane Central Register of Controlled Trials (CENTRAL) was conducted from database inception through December 2024, combining controlled vocabulary and free-text terms for ventilator-associated pneumonia, mechanical ventilation, and the four intervention categories of interest. Reference lists of included studies and relevant prior systematic reviews were hand-searched for additional eligible trials.

Eligibility criteria. Eligible studies were randomized controlled trials evaluating a nursing-implementable ventilator-associated pneumonia prevention strategy against standard care among mechanically ventilated adult intensive care unit patients, reporting ventilator-associated pneumonia incidence assessed using standardized clinical or surveillance-based diagnostic criteria consistent with American Thoracic Society/Infectious Diseases Society of America definitions. Studies evaluating pharmacological prophylaxis exclusively (such as selective digestive decontamination without a co-evaluated nursing-implementable component) and studies without a concurrent comparison group were excluded.

Study selection and data extraction. Two reviewers independently screened titles and abstracts, then full texts of potentially eligible records, with disagreements resolved through discussion or third-reviewer adjudication. Data extraction, including study design, sample characteristics, intervention category, comparator, outcome measures, and results, was performed independently by two reviewers using a standardized extraction form.

Risk of bias assessment. Risk of bias was assessed independently by two reviewers using the Cochrane Risk of Bias 2 (RoB 2) tool, evaluating bias arising from the randomization process, deviations from intended interventions, missing outcome data, measurement of the outcome, and selection of the reported result. Each study received an overall judgment of low, some concerns, or high risk of bias.

Data synthesis. Random-effects meta-analysis (restricted maximum likelihood estimation) pooled relative risks for ventilator-associated pneumonia incidence across studies. Statistical heterogeneity was quantified using the I² statistic. Pre-specified subgroup analysis stratified ventilator-associated pneumonia incidence by intervention category, with between-subgroup differences evaluated using a chi-square test. Secondary outcomes, intensive care unit length of stay, duration of mechanical ventilation, and mortality, were pooled separately using mean difference or relative risk as appropriate, where sufficient data were available across studies.

Results

The search identified 2,214 records, of which 1,687 remained after duplicate removal. Following title and abstract screening, 101 full-text articles were assessed for eligibility, and 18 randomized controlled trials, comprising 4,960 patients, met inclusion criteria (Figure 1). Included studies evaluated four intervention categories: oral care and antiseptic protocols (7 studies), subglottic secretion drainage (5 studies), semi-recumbent positioning (4 studies), and combined multicomponent bundles (2 studies), as summarized in Table 1. Risk of bias was judged low in 7 studies, some concerns in 8 studies, and high in 3 studies.

Pooled analysis of secondary outcomes showed a significant reduction in intensive care unit length of stay favoring intervention (mean difference −1.8 days, 95% CI −2.6 to −1.0, p < .001; k = 11) and a significant reduction in duration of mechanical ventilation (mean difference −1.3 days, 95% CI −2.0 to −0.6, p < .001; k = 9). Pooled mortality did not differ significantly between groups (RR 0.94, 95% CI 0.85–1.04, p = .23; k = 14), consistent with prior literature suggesting that ventilator-associated pneumonia prevention reduces infection incidence and associated morbidity without necessarily producing a detectable independent mortality benefit.

Discussion

This systematic review and meta-analysis found that nursing-implementable ventilator-associated pneumonia prevention strategies produced a significant, moderate-to-large reduction in pneumonia incidence, intensive care unit length of stay, and duration of mechanical ventilation, without a significant effect on mortality. The overall pooled effect (RR 0.61) is consistent with, and in the case of subglottic secretion drainage specifically comparable in magnitude to, effects reported in prior focused meta-analyses of individual intervention categories (Muscedere et al., 2011; Labeau et al., 2011), extending this literature by directly comparing effect magnitude across all four major nursing-implementable intervention categories within a single, updated synthesis.

The finding that combined multicomponent bundles and subglottic secretion drainage produced the two largest pooled effects, each substantially exceeding the effect observed for oral care or positioning alone, is consistent with the conceptual rationale underlying bundled prevention approaches such as the Institute for Healthcare Improvement’s ventilator bundle, which was explicitly designed around the observation that ventilator-associated pneumonia risk arises from multiple, simultaneously present modifiable pathways, aspiration, oropharyngeal colonization, and subglottic secretion pooling among them, such that addressing any single pathway in isolation, while still beneficial, leaves other contributing mechanisms unaddressed (Resar et al., 2005). The comparatively small number of combined-bundle trials contributing to this subgroup (k = 2), however, warrants caution in over-interpreting the precision of this specific estimate relative to the more extensively studied single-component categories.

The absence of a significant mortality effect, despite the substantial and statistically robust reduction in ventilator-associated pneumonia incidence itself, is consistent with a body of epidemiological literature questioning whether ventilator-associated pneumonia functions as an independent driver of mortality or primarily as a marker of the severity of the underlying critical illness that predisposed the patient to both prolonged ventilation and pneumonia risk in the first place (Zilberberg & Shorr, 2010; Rello et al., 2002). This distinction has practical relevance for how prevention program value should be communicated and justified within a health system: the case for these interventions rests most directly on reduced infection incidence, shortened mechanical ventilation and intensive care unit stay, and their associated resource and comfort benefits, rather than on an anticipated mortality reduction that this body of evidence does not clearly support.

The risk of bias pattern observed, with the deviations-from-intended-interventions and outcome-measurement domains showing the highest proportion of concerning judgments, reflects a structural limitation common to this literature rather than a correctable methodological weakness specific to individual studies, since full blinding of a positioning or oral care intervention is rarely feasible, and ventilator-associated pneumonia diagnostic criteria have themselves evolved and varied across the multi-decade period spanned by the included trials (American Thoracic Society/Infectious Diseases Society of America, 2005; Klompas et al., 2014).

Several limitations of this review should be considered. The moderate statistical heterogeneity observed (I² = 57%) indicates genuine variability in effect magnitude across studies that intervention-category subgroup analysis only partially explained, likely reflecting additional unmeasured variation in patient population, baseline ventilator-associated pneumonia rate, and specific implementation fidelity across studies and eras. The modest number of studies contributing to the combined-bundle subgroup limits the precision of this specific estimate and the ability to determine which particular bundle components drive its comparatively large effect. Finally, studies included in this review span more than two decades, during which both diagnostic criteria and baseline standard-of-care prevention practice have evolved, potentially limiting direct comparability of effect estimates across the oldest and most recent included trials.

Future research should prioritize adequately powered trials directly comparing combined multicomponent bundles against subglottic secretion drainage alone within the same study design, which would allow more precise head-to-head effect comparison than the indirect, between-study subgroup comparison possible in the present review, and should further examine which specific bundle components contribute most to the observed combined effect, to help intensive care units with constrained resources prioritize implementation. Taken together, these findings support the routine, nursing-implemented use of these prevention strategies, with particular emphasis on subglottic secretion drainage and combined multicomponent bundles where implementation resources permit, as an effective approach to reducing ventilator-associated pneumonia incidence and its associated length-of-stay burden in intensive care unit practice.

References

Alexiou, V. G., Ierodiakonou, V., Dimopoulos, G., & Falagas, M. E. (2009). Impact of patient position on the incidence of ventilator-associated pneumonia: A meta-analysis of randomized controlled trials. Journal of Critical Care, 24(4), 515–522.

American Thoracic Society, & Infectious Diseases Society of America. (2005). Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. American Journal of Respiratory and Critical Care Medicine, 171(4), 388–416.

Drakulovic, M. B., Torres, A., Bauer, T. T., Nicolas, J. M., Nogué, S., & Ferrer, M. (1999). Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: A randomised trial. The Lancet, 354(9193), 1851–1858.

Klompas, M., Branson, R., Eichenwald, E. C., Greene, L. R., Howell, M. D., Lee, G., Magill, S. S., Maragakis, L. L., Priebe, G. P., Speck, K., Yokoe, D. S., & Berenholtz, S. M. (2014). Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update. Infection Control & Hospital Epidemiology, 35(8), 915–936.

Kollef, M. H. (2004). Prevention of hospital-associated pneumonia and ventilator-associated pneumonia: A clinical trials-based update. American Journal of Respiratory and Critical Care Medicine, 170(11), 1146–1153.

Labeau, S. O., Van de Vyver, K., Brusselaers, N., Vogelaers, D., & Blot, S. I. (2011). Prevention of ventilator-associated pneumonia with oral antiseptics: A systematic review and meta-analysis. The Lancet Infectious Diseases, 11(11), 845–854.

Muscedere, J., Rewa, O., McKechnie, K., Jiang, X., Laporta, D., & Heyland, D. K. (2011). Subglottic secretion drainage for the prevention of ventilator-associated pneumonia: A systematic review and meta-analysis. Critical Care Medicine, 39(8), 1985–1991.

Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71.

Pileggi, C., Bianco, A., Flotta, D., Nobile, C. G. A., & Pavia, M. (2018). Subglottic secretion drainage for preventing ventilator-associated pneumonia: An updated meta-analysis and trial sequential analysis. Critical Care, 22, 65.

Rello, J., Ollendorf, D. A., Oster, G., Vera-Llonch, M., Bellm, L., Redman, R., & Kollef, M. H. (2002). Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest, 122(6), 2115–2121.

Resar, R., Pronovost, P., Haraden, C., Simmonds, T., Rainey, T., & Nolan, T. (2005). Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia. The Joint Commission Journal on Quality and Patient Safety, 31(5), 243–248.

Shi, Z., Xie, H., Wang, P., Zhang, Q., Wu, Y., Chen, E., Ng, L., Worthington, H. V., Needleman, I., & Furness, S. (2013). Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia. Cochrane Database of Systematic Reviews, 8, CD008367.

Wang, L., Li, X., Yang, Z., Tang, X., Yuan, Q., Deng, L., & Sun, X. (2012). Semi-recumbent position versus supine position for the prevention of ventilator-associated pneumonia in adults requiring mechanical ventilation. Cochrane Database of Systematic Reviews, 8, CD009946.

Zilberberg, M. D., & Shorr, A. F. (2010). Ventilator-associated pneumonia: The clinical pulmonary infection score as a surrogate for diagnostics and outcome. Clinical Infectious Diseases, 51(Supplement 1), S131–S135.

◆